News
TRFA
0.750
NaN%
--
Weekly Report: what happened at GCAND last week (1012-1016)?
Weekly Report · 3d ago
Greater Cannabis Reshapes Capital Structure and Governance Framework
TipRanks · 10/14 10:31
Weekly Report: what happened at GCAND last week (1005-1009)?
Weekly Report · 10/12 09:19
Weekly Report: what happened at GCAND last week (0928-1002)?
Weekly Report · 10/05 09:19
Weekly Report: what happened at GCAND last week (0921-0925)?
Weekly Report · 09/28 09:18
Greater Cannabis Announces New Chief Executive Officer
TipRanks · 09/21 21:19
Weekly Report: what happened at GCAND last week (0914-0918)?
Weekly Report · 09/21 09:18
Weekly Report: what happened at GCAN last week (0907-0911)?
Weekly Report · 09/14 09:19
Weekly Report: what happened at GCAN last week (0831-0904)?
Weekly Report · 09/07 09:18
Weekly Report: what happened at GCAN last week (0824-0828)?
Weekly Report · 08/31 09:20
Weekly Report: what happened at GCAN last week (0817-0821)?
Weekly Report · 08/24 09:20
Trafalgar International Launches U.S. Public Company Platform for Financial Services and Strategic Investment
PR Newswire · 08/17 19:08
Weekly Report: what happened at GCAN last week (0810-0814)?
Weekly Report · 08/17 09:20
Weekly Report: what happened at GCAN last week (0803-0807)?
Weekly Report · 08/10 09:19
Weekly Report: what happened at GCAN last week (0727-0731)?
Weekly Report · 08/03 09:19
Greater Cannabis rebrands as Trafalgar International, Inc.
TipRanks · 07/31 19:32
Weekly Report: what happened at GCAN last week (0720-0724)?
Weekly Report · 07/27 09:20
Weekly Report: what happened at GCAN last week (0713-0717)?
Weekly Report · 07/20 09:19
Weekly Report: what happened at GCAN last week (0706-0710)?
Weekly Report · 07/13 09:19
Greater Cannabis Undergoes Leadership Change and Debt Restructuring
TipRanks · 07/06 21:17
More
Webull provides a variety of real-time TRFA stock news. You can receive the latest news about Greater Cannabis through multiple platforms. This information may help you make smarter investment decisions.
About TRFA
The Greater Cannabis Company, Inc. is a biotechnology company. The Company is involved in additional research and development of cannabinoid-based therapeutics that reduce disruptive symptoms in patients suffering from neuropsychiatric disorders. The Company also focuses on developing new formulations around cannabinoid therapeutics. Its wholly owned subsidiary is Biocanrx, Inc.